Skip to main content
Top
Published in: International Journal of Mental Health and Addiction 1/2021

01-02-2021 | Brief Report

Medical Cannabis Pain Benefit, Risk and Effectiveness Perceptions Among Belarus Medical Students

Authors: Natallia Khamenka, Aliaksei Skuhareuski, Alexander Reznik, Richard Isralowitz

Published in: International Journal of Mental Health and Addiction | Issue 1/2021

Login to get access

Excerpt

For centuries, the chemicals in cannabis and cannabinoids have been used for medical purposes. The psychoactive compound of cannabis, THC or tetrahydrocannabinols, is linked to a sense of euphoria or a “feel good” condition. A second compound is cannabidiol or CBD, not linked to causing a “high,” is thought to be responsible for many cannabis therapeutic effects (NIDA 2019). …
Literature
go back to reference Abrams, D. I. (2018). The therapeutic effects of Cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report. European Journal of Internal Medicine, 49, 7–11.CrossRef Abrams, D. I. (2018). The therapeutic effects of Cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report. European Journal of Internal Medicine, 49, 7–11.CrossRef
go back to reference Baldwin, D. C., Hughes, P. H., Conard, S. E., Storr, C. L., & Sheehan, D. V. (1991). Substance use among senior medical students: a survey of 23 medical schools. Jama, 265(16), 2074–2078.CrossRef Baldwin, D. C., Hughes, P. H., Conard, S. E., Storr, C. L., & Sheehan, D. V. (1991). Substance use among senior medical students: a survey of 23 medical schools. Jama, 265(16), 2074–2078.CrossRef
go back to reference Chan, M. H., Knoepke, C. E., Cole, M. L., McKinnon, J., & Matlock, D. D. (2017). Colorado medical students’ attitudes and beliefs about marijuana. Journal of General Internal Medicine, 32(4), 458–463.CrossRef Chan, M. H., Knoepke, C. E., Cole, M. L., McKinnon, J., & Matlock, D. D. (2017). Colorado medical students’ attitudes and beliefs about marijuana. Journal of General Internal Medicine, 32(4), 458–463.CrossRef
go back to reference Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., & La Barbera, D. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry, 6(5), 427–436.CrossRef Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., & La Barbera, D. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry, 6(5), 427–436.CrossRef
go back to reference Doblin, R., & Kleiman, M. A. (1991). Medical use of marijuana. Annals of Internal Medicine, 114(9), 809–810.CrossRef Doblin, R., & Kleiman, M. A. (1991). Medical use of marijuana. Annals of Internal Medicine, 114(9), 809–810.CrossRef
go back to reference Gage, S. H. (2019). Cannabis and psychosis: triangulating the evidence. The Lancet Psychiatry, 6(5), 364–365.CrossRef Gage, S. H. (2019). Cannabis and psychosis: triangulating the evidence. The Lancet Psychiatry, 6(5), 364–365.CrossRef
go back to reference Isralowitz, R., & Reznik, A. (2018). Cannabis use in Israel: a cross sectional overview of multiple study groups. International Journal of Mental Health and Addiction, 16(4), 832–842.CrossRef Isralowitz, R., & Reznik, A. (2018). Cannabis use in Israel: a cross sectional overview of multiple study groups. International Journal of Mental Health and Addiction, 16(4), 832–842.CrossRef
go back to reference Kilmer, J. R., Hunt, S. B., Lee, C. M., & Neighbors, C. (2007). Marijuana use, risk perception, and consequences: Is perceived risk congruent with reality? Addictive Behaviors, 32(12), 3026–3033.CrossRef Kilmer, J. R., Hunt, S. B., Lee, C. M., & Neighbors, C. (2007). Marijuana use, risk perception, and consequences: Is perceived risk congruent with reality? Addictive Behaviors, 32(12), 3026–3033.CrossRef
go back to reference Kondrad, E., & Reid, A. (2013). Colorado family physicians' attitudes toward medical marijuana. The Journal of the American Board of Family Medicine, 26(1), 52–60.CrossRef Kondrad, E., & Reid, A. (2013). Colorado family physicians' attitudes toward medical marijuana. The Journal of the American Board of Family Medicine, 26(1), 52–60.CrossRef
go back to reference Krcevski-Skvarc, N., Wells, C., & Häuser, W. (2018). Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: a survey of the status in the chapters of the European Pain Federation. European Journal of Pain, 22(3), 440–454.CrossRef Krcevski-Skvarc, N., Wells, C., & Häuser, W. (2018). Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: a survey of the status in the chapters of the European Pain Federation. European Journal of Pain, 22(3), 440–454.CrossRef
go back to reference Mirelman, D., Waissengrin, B., Goldway, N., Sharon, H., Brill, S., & Wolf, I. (2019). Use of medical cannabis: perceptions of Israeli oncologists. The Lancet Oncology, 20(4), 475–477.CrossRef Mirelman, D., Waissengrin, B., Goldway, N., Sharon, H., Brill, S., & Wolf, I. (2019). Use of medical cannabis: perceptions of Israeli oncologists. The Lancet Oncology, 20(4), 475–477.CrossRef
Metadata
Title
Medical Cannabis Pain Benefit, Risk and Effectiveness Perceptions Among Belarus Medical Students
Authors
Natallia Khamenka
Aliaksei Skuhareuski
Alexander Reznik
Richard Isralowitz
Publication date
01-02-2021
Publisher
Springer US
Published in
International Journal of Mental Health and Addiction / Issue 1/2021
Print ISSN: 1557-1874
Electronic ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-019-00152-8

Other articles of this Issue 1/2021

International Journal of Mental Health and Addiction 1/2021 Go to the issue